CM Hospitalar

CM Hospitalar Financial Leverage

The Financial Leverage (Equity Multiplier) of CM Hospitalar (VVEO3.SA) as of Nov 19, 2026 is 4.64. In the previous year, Financial Leverage (Equity Multiplier) was 4.95 — a change of -6.39% (lower).

Financial Leverage

4.64

YoY

-6.39%

Last updated:

Financial Leverage (Equity Multiplier) of CM Hospitalar is 2025 4.64 . Financial Leverage (Equity Multiplier) of CM Hospitalar was 2024 4.95 . It decreases by -6.39% lower compared to the previous year.

The CM Hospitalar Financial Leverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financial Leverage
Date
Financial Leverage
Jan 1, 2018
6.08 BRL
Jan 1, 2019
5.48 BRL
Jan 1, 2020
3.83 BRL
Jan 1, 2021
3.21 BRL
Jan 1, 2022
4.19 BRL
Jan 1, 2023
3.10 BRL
Jan 1, 2024
4.95 BRL
Jan 1, 2025
4.64 BRL
The CM Hospitalar Financial Leverage history
YEARFinancial LeverageYoY
4.64-6.39%
4.95+59.97%
3.10-26.12%
4.19+30.74%
3.21-16.19%
3.83-30.13%
5.48-9.90%
6.08+51.25%
4.02—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

CM Hospitalar Stock analysis

What does CM Hospitalar do? CM Hospitalar SA provides healthcare services as a middleman between pharmaceutical industries and hospitals, clinics, home care, and health institutions in both private and public markets. The company operates throughout Brazil with a commercial and logistical structure, focusing on the export, import, production, representation, storage, distribution, and shipment of medicines, including special control and wholesale trade. It generates revenue through its role as an intermediary in the health products trade, serving institutions across Brazil's private and public healthcare sectors. The firm's business model relies on its comprehensive distribution network for medicines and hospital supplies, acting as a key link in the supply chain. By handling export, import, production, and wholesale activities, CM Hospitalar SA facilitates transactions between manufacturers and healthcare providers, ensuring efficient delivery of health products to its clients. Its medium and long-term strategy includes acquiring companies in the segment to strengthen its commercial presence nationwide. With 6,000 full-time employees, the company supports its operations across Brazil, managing the entire supply chain from production to distribution. CM Hospitalar SA's revenue streams are derived from its intermediary services in the health products trade, targeting hospitals, clinics, home care services, and health institutions that require consistent access to medicines and hospital supplies through its established logistics and commercial infrastructure. CM Hospitalar is one of the most popular companies on Eulerpool.

Frequently Asked Questions about CM Hospitalar stock

Financial Leverage (Equity Multiplier) of CM Hospitalar is 4.64 in 2025.

Financial Leverage (Equity Multiplier) of CM Hospitalar changed from 4.95 to 4.64, representing a -6.39% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) CM Hospitalar since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s CM Hospitalar with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — CM Hospitalar

All Key Metrics — CM Hospitalar